The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.
Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ.
Esslinger CS, et al. Among authors: bridges rj.
Neuropharmacology. 2005 Nov;49(6):850-61. doi: 10.1016/j.neuropharm.2005.08.009. Epub 2005 Sep 23.
Neuropharmacology. 2005.
PMID: 16183084